Boston Scientific, Lumenis renew agreement

    March 9, 2012
    Medical device maker Boston Scientific and holmium laser technology developer Lumenis recently inked a five-year contract extending their existing commercial agreement.

    Medical device maker Boston Scientific (NYSE: BSX; Marlborough, MA) and holmium laser technology developer Lumenis (Yokneam, Israel) recently inked a five-year contract extending their existing commercial agreement.

    The two companies will promote continued investments in laser and fiber product development for urologic applications. Also under the agreement, Boston Scientific will continue as the exclusive US distributor for Lumenis' holmium laser fibers, which are designed for use with surgical lasers.

    -----

    Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

    Follow OptoIQ on your iPhone; download the free app here.

    Subscribe now to BioOptics World magazine; it's free!

    Continue Reading

    Voice your opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!